EGFR and non-small cell lung carcinoma: These compounds suppress self-renewal capacity, inhibit cell proliferation via activation of the intrinsic apoptotic pathway, and downregulate the CypA/CD147 axis as well as EGFR signaling in NSCLC cancer stem cells (CSCs).